DIHYDROERGOTAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dihydroergotamine, and when can generic versions of Dihydroergotamine launch?
Dihydroergotamine is a drug marketed by Baxter Hlthcare Corp, Cipla, Gland, Hikma, Hikma Pharms, Milla Pharms, Padagis Us, Sagent Pharms Inc, Amneal, Rubicon Research, and Somerset Theraps Llc. and is included in thirteen NDAs.
The generic ingredient in DIHYDROERGOTAMINE is dihydroergotamine mesylate. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dihydroergotamine
A generic version of DIHYDROERGOTAMINE was approved as dihydroergotamine mesylate by HIKMA on June 9th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIHYDROERGOTAMINE?
- What are the global sales for DIHYDROERGOTAMINE?
- What is Average Wholesale Price for DIHYDROERGOTAMINE?
Summary for DIHYDROERGOTAMINE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 13 |
| Drug Prices: | Drug price information for DIHYDROERGOTAMINE |
| DailyMed Link: | DIHYDROERGOTAMINE at DailyMed |
US Patents and Regulatory Information for DIHYDROERGOTAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | INJECTABLE;INJECTION | 216747-001 | Jan 7, 2025 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | INJECTABLE;INJECTION | 040475-001 | Apr 28, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | INJECTABLE;INJECTION | 040453-001 | Jun 9, 2003 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Rubicon Research | DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 216881-001 | Jun 22, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sagent Pharms Inc | DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | INJECTABLE;INJECTION | 207264-001 | Jul 11, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
